New Delhi, July 24 -- The Indian government's discussions with US pharmaceutical major Moderna for making its mRNA technology-based Covid-19 vaccine part of the country's vaccine programme may take till 2022 because the company's supplies are "fully booked till 2021", according to an internal government report.p11

Published by HT Digital Content Services with permission from HT Lucknow....